Towards universal therapeutics for memory disorders

Trends in Pharmacological Sciences

Volumn 36, Issue 6, 2015, Pages 384-394

  Sun, Miao Kun ^a   Nelson, Thomas J ^a   Alkon, Daniel L ^a  

^a Blanchette Rockefeller Neurosciences Institute   (United States)

Author keywords

Brain derived neurotrophic factor; Learning and memory; Memory disorders; Post traumatic stress disorder; Protein kinase C; Stem cell

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; BRYOSTATIN 1; DONEPEZIL; GALANTAMINE; HISTONE DEACETYLASE INHIBITOR; MEMANTINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; RIVASTIGMINE; ROSIGLITAZONE; NEUROPROTECTIVE AGENT;

AGING; ALZHEIMER DISEASE; ARTICLE; ENVIRONMENTAL ENRICHMENT; EXERCISE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; MEMORY; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NERVE STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; STATE DEPENDENT LEARNING; STEM CELL TRANSPLANTATION; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; ANIMAL; DRUG EFFECTS; MEMORY DISORDERS; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; SYNAPSE;

ANIMALS; HUMANS; MEMORY DISORDERS; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROPROTECTIVE AGENTS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84935026139     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.04.004     Document Type: Review

References (124)

1. Nelson, T.J. and Alkon, D.L. (2014) Molecular regulation of synaptogenesis during associative learning and memory. Brain Res. Published online December 5, 2014. http://dx.doi.org/10.1016/.brainres.2014.11.054
2. Mullard, A. (2012) Sting of Alzheimer's failures offset by upcoming prevention trials. Nat. Rev. Drug Discov. 11, 657-660
3. Herrmann, N. et al. (2011) Current and emerging drug treatment options for Alzheimer's disease: a systematic review. Drugs 71, 2031-2065
4. Nelson, T.J. et al. (2015) Signaling pathways involved in cognitive enhancement. In Cognitive Enhancement (1st edn) (Knafo, S. and Venero, C., eds), Elsevier (in press)
5. Hongpaisan, J. and Alkon, D.L. (2007) A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC. Proc. Natl. Acad. Sci. U.S.A. 104, 19571-19576
6. Bourne, J.N. and Harris, K.M. (2008) Balancing structure and function at hippocampal dendritic spines. Annu. Rev. Neurosci. 31, 47-67
7. Wang, J.X. et al. (2014) Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science 345, 1054-1057
8. La Joie, R. et al. (2014) Intrinsic connectivity identifies the hippocampus as a main crossroad between Alzheimer's and semantic dementia-targeted networks. Neuron 81, 1417-1428
9. Staresina, B.P. et al. (2013) Reversible information flow across the medial temporal lobe: the hippocampal links cortical modules during memory retrieval. J. Neurosci. 33, 14184-14192
10. Kim, J. et al. (2010) Reactivation of fear memory renders consolidated amygdala synapses labile. J. Neurosci. 30, 9631-9640
11. Alkon, D.L. et al. (2005) Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning. Proc. Natl. Acad. Sci. U.S.A. 102, 16432-16437
12. Lee, S.H. et al. (2008) Synaptic protein degradation underlies destabilization of retrieved fear memory. Science 319, 1253-1256
13. Kaang, B.K. and Choi, J.H. (2012) Synaptic protein degradation in memory reorganization. Adv. Exp. Med. Biol. 970, 221-240
14. Da Silva, W.C. et al. (2013) Memory reconsolidation and its maintenance depend on L-voltage-dependent calcium channels and CaMKII functions regulating protein turnover in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 110, 6566-6570
15. + channel cascade. Trends Neurosci. 21, 529-537
16. Sun, M-K. and Alkon, D.L. (2014) The 'memory kinases': roles of PKC isoforms in signal processing and memory formation. Proc. Mol. Biol. Transl. Sci. 122, 31-59
17. Olds, J.L. et al. (1989) Imaging of memory-specific changes in the distribution of protein kinase C in the hippocampus. Science 245, 866-869
18. Lim, C.S. and Alkon, D.L. (2014) PKCe promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Aβ degradation in brain neurons. PLoS ONE 9, e97756
19. Kellner, Y. et al. (2014) The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity. Front. Synaptic Neurosci. 6, 5
20. Alomari, M. et al. (2013) Forced and voluntary exercises equally improve spatial learning and memory and hippocampal BDNF levels. Behav. Brain Res. 247, 34-39
21. Ji, Y. et al. (2010) Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nat. Neurosci. 13, 302-309
22. 2+ channels. J. Biol. Chem. 275, 17269-17275
23. Tapia-Arancibia, L. et al. (2008) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 59, 201-220
24. Yasuda, S. et al. (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol. Psychiatry 14, 51-59
25. de Groot, M. et al. (2013) Levetiracetam improves verbal memory in high-grade glioma patients. Neuro Oncol. 15, 216-223
26. Xuan, A.G. et al. (2015) Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease. Mol. Neurobiol. 51, 300-312
27. Nelson, T.J. et al. (2008) Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur. J. Pharmacol. 585, 76-87
28. Li, L. et al. (2014) Hippocampal protein kinase C family members in spatial memory retrieval in the mouse. Behav. Brain Res. 258, 202-207
29. Rodríguez-Durán, L.F. and Escobar, M.L. (2014) NMDA receptor activation and PKC but not PKA lead to the modification of the long-term potentiation in the insular cortex induced by conditioned taste aversion: differential role of kinases in metaplasticity. Behav. Brain Res. 266, 58-62
30. Lucke-Wold, B. et al. (2014) Bryostatin-1 restores blood brain barrier integrity following blast-induced traumatic brain injury. Mol. Neurobiol. Published online October 10, 2014. http://dx.doi.org/10.1007/s12035-014-8902-7
31. Zisopoulou, S. et al. (2013) PKC-epsilon activation is required for recognition memory in the rat. Behav. Brain Res. 253, 280-289
32. Asimaki, O. et al. (2011) Cannabinoid receptor 1 induces a biphasic ERK activation via multiprotein signaling complex formation of proximal kinases PKCε, Src, and Fyn in primary neurons. Neurochem. Int. 58, 135-144
33. Zhao, W.Q. et al. (2003) Secretion of annexin II via activation of insulin receptor and insulin-like growth factor receptor. J. Biol. Chem. 278, 4205-4215
34. Sinai, L. et al. (2010) Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala. Learn. Mem. 17, 364-371
35. Yang, K. et al. (2011) Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases. EMBO J. 31, 805-816
36. Xu, J. et al. (2014) Hippocampal metaplasticity is required for the formation of temporal associative memories. J. Neurosci. 34, 16762-16773
37. Hongpaisan, J. et al. (2011) PKCε activation prevents synaptic loss, Ab elevation, and cognitive deficits in Alzheimer's disease transgenic mice. J. Neurosci. 31, 630-643
38. Phillips, H.S. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695-702
39. Howells, D.W. et al. (2000) Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp. Neurol. 166, 127-135
40. Zuccato, C. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498
41. Sun, M-K. et al. (2008) Post-stroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc. Natl. Acad. Sci. U.S.A. 105, 13620-13625
42. Hebert, L.E. et al. (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778-1783
43. Rhinn, H. et al. (2013) Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature 500, 45-50
44. Eikelenboom, P. et al. (2002) Neuroinflammation in Alzheimer's disease and prion disease. Glia 40, 232-239
45. Cha, M.Y. et al. (2012) Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS ONE 7, e34929
46. Holmes, C. et al. (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled Phase I trial. Lancet 372, 216-223
47. Medina, M. and Avila, J. (2015) Further understanding of tau phosphorylation: implications for therapy. Expert Rev. Neurother. 15, 115-122
48. Huang, Y. and Mucke, L. (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222
49. Fowler, S.W. et al. (2014) Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J. Neurosci. 34, 7871-7885
50. Arendt, T. (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167-179
51. Selkoe, D.J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
52. Palop, J.J. et al. (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443, 768-773
53. Scheff, S.W. et al. (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501-1508
54. Khan, T.K. et al. (2015) PKCε deficits in Alzheimer's disease brains and skin fibroblasts. J. Alzheimers Dis. 43, 491-509
55. Lee, S-T. et al. (2012) miR-206 regulates brain-derived neurotrophic factor in Alzheimer's disease model. Ann. Neurol. 72, 269-277
56. Finke, C. et al. (2013) Neural correlates of short-term memory reorganization in humans with hippocampal damage. J. Neurosci. 33, 11061-11069
57. Frisardi, V. et al. (2010) Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid. Curr. Alzheimer Res. 7, 40-55
58. Ghezzi, L. et al. (2013) Disease-modifying drugs in Alzheimer's disease. Drug Des. Dev. Ther. 7, 1471-1479
59. Mitani, Y. et al. (2012) Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J. Neurosci. 32, 2037-2050
60. Coric, V. et al. (2012) Safety and tolerability of the γ-secretase inhibitor avagacestat in a Phase 2 study of mild to moderate Alzheimer disease. Arch. Neurol. 69, 1430-1440
61. Doody, R.S. et al. (2013) A Phase 3 trial of semagacestat for treatment of Alzheimer's disease. N. Engl. J. Med. 369, 341-350
62. Mitani, Y. et al. (2014) Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates. Neuropharmacology 79, 412-419
63. Lu, B. et al. (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat. Rev. Neurosci. 14, 401-416
64. Revilla, S. et al. (2014) Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells. CNS Neurosci. Ther. 20, 961-972
65. Kazim, S.F. et al. (2014) Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 71, 110-130
66. Burke, R.M. et al. (2013) BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 26, 19567-19572
67. Pascual-Lucas, M. et al. (2014) Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Mol. Med. 6, 1246-1262
68. Blurton-Jones, M. et al. (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 106, 13594-13599
69. Nagahara, A.H. et al. (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 15, 331-337
70. Nagahara, A.H. et al. (2013) Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J. Neurosci. 33, 15596-15602
71. Wang, F. et al. (2014) NGF and TERT co-transfected BMSCs improve the restoration of cognitive impairment in vascular dementia Rats. PLoS ONE 9, e98774
72. Tan, Z. et al. (2013) Bryostatin improves survival and reduces ischemic brain injury in aged rats after acute ischemic stroke. Stroke 44, 3490-3497
73. Sun, M-K. et al. (2009) Post-ischemic PKC activation rescues retrograde and anterograde long-term memory. Proc. Natl. Acad. Sci. U.S.A. 106, 14676-14680
74. Zohar, O. et al. (2011) PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiol. Dis. 41, 329-337
75. Sun, M-K. et al. (2014) Bryostatin-1 restores hippocampal synapses and spatial learning and memory in adult fragile X mice. J. Pharmacol. Exp. Ther. 349, 393-401
76. Sun, M-K. and Alkon, D.L. (2005) Dual effects of bryostatin-1 on spatial memory and depression. Eur. J. Pharmacol. 512, 43-51
77. Hescham, S. et al. (2013) Deep brain stimulation in dementia-related disorders. Neurosci. Biobehav. Rev. 37, 2666-2675
78. Creed, M. et al. (2015) Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology. Science 347, 659-664
79. Mirsaeedi-Farahani, K. et al. (2015) Deep brain stimulation for Alzheimer disease: a decision and cost-effectiveness analysis. J. Neurol. Published online March 6, 2015. http://dx.doi.org/10.1007/s00415-015-7688-5
80. Tang, V. et al. (2015) Evidence of improved immediate verbal memory and diminished category fluency following STN-DBS in Chinese-Cantonese patients with idiopathic Parkinson's disease. Neurosci. Res. Published online February 24, 2015. http://dx.doi.org/10.1007/s10072-015-2117-1
81. Fell, J. et al. (2013) Memory modulation by weak synchronous deep brain stimulation: a pilot study. Brain Stimul. 6, 270-273
82. Wang, F. et al. (2015) The neuroprotection of repetitive transcranial magnetic stimulation pre-treatment in vascular dementia rats. J. Mol. Neurosci. 56, 198-204
83. Blumenfeld, R.S. et al. (2014) The effects of lateral prefrontal transcranial magnetic stimulation on item memory encoding. Neuropsychologia 53, 197-202
84. Xuan, W. et al. (2014) Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice. J. Biomed. Opt. 19, 108003
85. Xuan, W. et al. (2014) Low-level laser therapy for traumatic brain injury in mice increases brain-derived neurotrophic factor (BDNF) and synaptogenesis. J. Biophotonics Published online September 8, 2014. http://dx.doi.org/10.1002/jbio.201400069
86. Hu, J.P. et al. (2014) Exercise improves cognitive function in aging patients. Int. J. Clin. Exp. Med. 7, 3144-3149
87. Liu-Ambrose, T. and Eng, J.J. (2014) Exercise training and recreational activities to promote executive functions in chronic stroke: a proof-of-concept study. J. Stroke Cerebrovasc. Dis. 24, 130-137
88. Clemenson, G.D. et al. (2015) Enrichment rescues contextual discrimination deficit associated with immediate shock. Hippocampus 25, 385-392
89. Mainardi, M. et al. (2014) Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice. Front. Aging Neurosci. 6, 1
90. Johnson, E.M. et al. (2013) Environmental enrichment protects against functional deficits caused by traumatic brain injury. Front. Behav. Neurosci. 7, 44
91. Li, M. et al. (2014) Stem cell treatment for Alzheimer's disease. Int. J. Mol. Sci. 15, 19226-19238
92. Tong, L.M. et al. (2014) Inhibitory interneuron progenitor transplantation restores normal learning and memory in ApoE4 knock-in mice without or with Aβ accumulation. J. Neurosci. 43, 9506-9515
93. Kanamaru, T. et al. (2015) Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease. Brain Res. 1605, 49-58
94. Park, D. et al. (2013) Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. J. Neurosci. Res. 91, 660-670
95. Liu, Y. et al. (2013) Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 31, 440-447
96. Cui, L. et al. (2014) NF-κB is involved in brain repair by stem cell factor and granulocyte-colony stimulating factor in chronic stroke. Exp. Neurol. 263, 17-27
97. Zhang, W. et al. (2014) Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease. J. Neurosci. Res. 92, 185-194
98. Berg, J. et al. (2015) Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids. Stem Cell Rev. 11, 133-149
99. Mu, S. et al. (2014) Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model. PLoS ONE 9, e101185
100. Yang, H.Y. et al. (2015) Transplantation of bone marrow mesenchymal stem cells promotes learning and memory functional recovery and reduces hippocampal damage in rats with alcohol-associated dementia. Transplantation 99, 492-499
101. Mauch, D.H. et al. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357
102. Sen, A. et al. (2012) Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon. J. Biol. Chem. 287, 15947-15958
103. Liu, C-C. et al. (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106-118
104. Yamada, M. (2015) Cerebral amyloid angiopathy: emerging concepts. J. Stroke 17, 17-30
105. Jahrling, J.B. et al. (2014) PPARγ recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement. J. Neurosci. 34, 4054-4063
106. Denner, L.A. et al. (2012) Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways. J. Neurosci. 32, 16725-16735
107. Plattner, F. et al. (2014) Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron 81, 1070-1083
108. Ouk, T. et al. (2014) Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia. J. Cereb. Blood Flow Metab. 34, 542-551
109. Pisanu, A. et al. (2014) Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Neurobiol. Dis. 71, 280-291
110. Gold, M. et al. (2010) Rosiglitazone monotherapy in mild-to moderate Alzheimer's disease: results from a randomized, double-blind, placebo controlled Phase III study. Dement. Geriatr. Cogn. Disord. 30, 131-146
111. Orr, A.L. et al. (2014) β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition. Neuron 82, 1334-1345
112. Segev, A. et al. (2013) Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology 39, 919-933
113. Guo, H.B. et al. (2015) Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation. Neuroscience 290C, 530-542
114. Salemi, J. et al. (2011) Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol. Neurodegener. 6, 3
115. Kim, J.Y. et al. (2014) Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci. Ther. 21, 309-319
116. Banta Lavenex, P. et al. (2015) Human short-term spatial memory: precision predicts capacity. Cogn. Psychol. 77, 1-19
117. Nieto-Gonzalez, J.L. et al. (2015) Presynaptic plasticity as a hallmark of rat stress susceptibility and antidepressant response. PLoS ONE 10, e0119993
118. Sun, M.K. and Alkon, D.L. (2006) Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J. Pharmacol. Exp. Ther. 316, 926-932
119. Nadeau, S.E. et al. (2014) Cognitive effects of treatment of depression with repetitive transcranial magnetic stimulation. Cogn. Behav. Neurol. 27, 77-87
120. Mathai, A. et al. (2015) Reduced cortical innervation of the subthalamic nucleus in MPTP-treated Parkinsonian monkeys. Brain 138, 946-962
121. Munsie, L.N. et al. (2015) Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N. Hum. Mol. Genet. 24, 1691-1703
122. Murmu, R.P. et al. (2015) Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease. J. Neurosci. 35, 287-298
123. Warmus, B.A. et al. (2014) Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia. J. Neurosci. 34, 16482-16495
124. Gascon, E. et al. (2014) Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat. Med. 20, 1444-1451